Top Companies in the Pathology Laboratories Market
- Labcorp
- Quest Diagnostics
- BioReference Laboratories
- Sonic Healthcare
- Eurofins Scientific
- Mayo Clinic Laboratories
- ARUP Laboratories
- Pathology Partners
- Charles River Laboratories
- ICON plc (Central labs)
- Thermo Fisher Scientific (Diagnostic services)
- Cerba Healthcare
- SRL Diagnostics
- Dr. Lal PathLabs
- MedGenome Labs
- Genoptix (Exact Sciences)
- Unilabs
- CBLPath, Inc.
- Strata Pathology
- Inovie Laboratories
Market Growth
The pathology laboratories market size is calculated at US$ 380.95 billion in 2024, grew to US$ 412.19 billion in 2025, and is projected to reach around US$ 834.44 billion by 2034. The market is expanding at a CAGR of 8.2% between 2025 and 2034.
Value Chain Analysis
R&D
The goals of R&D in pathology labs are automation, quicker turnaround, and increased diagnostic accuracy. Next-generation sequencing for personalized medicine, digital pathology, and AI-powered image analysis are important fields. To enhance disease detection, innovations also focus on biomarker discovery and molecular diagnostics.
Major players driving advancements are Roche, Philips, Thermo Fisher Scientific, Agilent Technologies, and Leica Biosystems.
Clinical Trials & Regulatory Approvals
Pathology labs undergo strict regulatory checks to ensure accuracy, safety, and compliance. Approvals from the FDA (U.S.), CE (Europe), and CDSCO (India) are vital, especially for AI-enabled and digital pathology systems. Clinical trials are essential to validate performance and data security, particularly in molecular and genetic testing.
Key companies focusing on regulatory-compliant solutions include Roche, Quest Diagnostics, Labcorp, Philips, and Thermo Fisher Scientific.
Patient Support & Services
In pathology labs, patient support places an emphasis on improved results, trust, and ease of access. For disease monitoring, labs now provide telepathology digital reports, home sample collection, and AI-driven insights. Further improving accessibility are outreach initiatives in underserved areas and integration with hospital EHRs.
Key players providing strong patient support include Quest Diagnostics, Labcorp, Roche, Sonic Healthcare, and SRL Diagnostics
Latest Announcements by Industry Leaders
- 14 July 2025, Dreampath Diagnostics announced a funding round launched for digital pathology solutions. The CEO of the company stated that "Pathology labs are a critical part of the global healthcare ecosystem, yet many still rely on manual, error-prone processes for sample archiving and retrieval."
- 25 February 2025, SigmaCore announced LabVizor launched in collaboration with American Oncology Network. The CEO of the company stated, "We are thrilled that AON has chosen LabVizor to enhance its diagnostic workflows." The cloud-based system streamlines pathology reporting for oncologists nationwide. It also improves data accuracy, compliance, and physician-patient communication.
Recent Developments in the Pathology Laboratories Market
- In May 2025, Mopec Group announced a strategic partnership with Lumea to integrate digital pathology and AI-powered imaging tools at the grossing station in pathology workflows. The partnership will streamline specimen evaluation and improve accuracy in pathology labs. This marks a step toward fully digitized workflows in anatomical pathology.
- In June 2025, Leica Biosystems announced the unveiling of its next-generation digital pathology portfolio at ECDP 2025, including high-performance scanners and intelligent software. The portfolio is designed to support faster image analysis and greater interoperability in digital pathology. Leica’s innovations reflect its long-term focus on advancing precision medicine.
- In March 2025, Metropolis Healthcare announced the acquisition of Scientific Pathology to expand its diagnostic capabilities in western Uttar Pradesh (India). The acquisition strengthens Metropolis’s regional footprint and enhances access to advanced testing services for patients. This move also demonstrates consolidation trends in the Indian pathology market.
Become a valued research partner with us, please feel free to contact us at sales@towardshealthcare.com
